Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type I, obesity and related conditions

Details for Australian Patent Application No. 2005298692 (hide)

Owner Solvay Pharmaceuticals GmbH

Inventors Gregory, Peter-Colin; Lange, Josephus Hubertus Maria; Firnges, Michael; Antel, Jochen; Waldeck, Harald

Agent Watermark

Pub. Number AU-A-2005298692

PCT Pub. Number WO2006/045799

Priority 04105265.5 25.10.04 EP; 60/621,077 25.10.04 US; 60/651,625 11.02.05 US

Filing date 25 October 2005

Wipo publication date 4 May 2006

International Classifications

A61K 31/00 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/54 (2006.01) - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/00 (2006.01) Investigating or analysing materials by specific methods not covered by groups

Event Publications

17 May 2007 PCT application entered the National Phase

  PCT publication WO2006/045799 Priority application(s): WO2006/045799

24 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005298693-Novel diazabicyclic aryl derivatives and their medical use

2005298689-Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof